CBP Stock Overview
Provides revenue cycle consultative services and solutions in the United States. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Certive Solutions Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.01 |
52 Week High | CA$0.035 |
52 Week Low | CA$0.01 |
Beta | 0.48 |
11 Month Change | 0% |
3 Month Change | -33.33% |
1 Year Change | n/a |
33 Year Change | -83.33% |
5 Year Change | -80.00% |
Change since IPO | -92.86% |
Recent News & Updates
Recent updates
Shareholder Returns
CBP | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | 0% | 0.2% | 0.7% |
1Y | n/a | 97.0% | 21.7% |
Return vs Industry: Insufficient data to determine how CBP performed against the Canadian Healthcare Services industry.
Return vs Market: Insufficient data to determine how CBP performed against the Canadian Market.
Price Volatility
CBP volatility | |
---|---|
CBP Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 8.1% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CBP's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine CBP's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Tom Marreel | certivehealth.com |
Certive Solutions Inc. provides revenue cycle consultative services and solutions in the United States. It offers healthcare revenue cycle management services and management solutions. It is also involved in the selling and servicing a cybersecurity suite of products to the healthcare industry.
Certive Solutions Inc. Fundamentals Summary
CBP fundamental statistics | |
---|---|
Market cap | CA$1.78m |
Earnings (TTM) | -CA$2.21m |
Revenue (TTM) | CA$1.82m |
1.0x
P/S Ratio-0.8x
P/E RatioIs CBP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CBP income statement (TTM) | |
---|---|
Revenue | US$1.30m |
Cost of Revenue | US$955.16k |
Gross Profit | US$344.81k |
Other Expenses | US$1.92m |
Earnings | -US$1.58m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0089 |
Gross Margin | 26.52% |
Net Profit Margin | -121.51% |
Debt/Equity Ratio | -50.4% |
How did CBP perform over the long term?
See historical performance and comparison